Welcome to our dedicated page for PishPosh news (Ticker: BABY), a resource for investors and traders seeking the latest updates and insights on PishPosh stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect PishPosh's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of PishPosh's position in the market.
Natus Sensory has announced three key executive appointments to strengthen its global leadership team, demonstrating its commitment to innovation in hearing, balance, and newborn care sectors.
Lon Nelson joins as Chief Commercial Officer to lead global Sales, Marketing Communications, Service, and Clinical Education. Kirill Shalyaev becomes Business Unit Leader for Global Newborn Care, bringing 15+ years of experience from companies like GE Healthcare and Philips Healthcare. Carsten Kind will join as Business Unit Leader for Global Hearing & Balance in May 2025, known for his successful tenure as President of Interacoustics A/S.
CEO Peter Reimer expressed enthusiasm about how these appointments will help advance the company's strategy to lead through innovation, enhance customer engagement, and expand global impact.
Natus Sensory has officially launched the ICS® Dizcovery VNG, a revolutionary videonystagmography solution, at the American Academy of Audiology's Annual Convention in New Orleans. This innovative device features all-in-one, plug-and-play goggles integrated with unified diagnostic software for comprehensive vestibular assessment.
The system's key features include:
- Portable design requiring no external hardware like light bars
- Integrated Freedom™ Laser for stimulus presentation
- High-resolution video and precision optics for accurate eye-tracking
- Seamless integration with Otosuite Vestibular software
CEO Peter Reimer emphasizes the system's ability to streamline clinical workflows and enhance diagnostic precision. The ICS Dizcovery is now available for immediate shipping in the United States, with live demonstrations being conducted at booth #401 during AAA 2025.
PishPosh, Inc. (NASDAQ: BABY), an online retailer of premium baby products, announced the postponement of its previously planned underwritten public offering originally priced on March 7, 2023. The shares were supposed to begin trading on the Nasdaq Capital Market on March 8, 2023, with the offering's closure expected around March 10, 2023. The company aims to defer the IPO for a later date, focusing on its growth strategy in the meantime. PishPosh has established itself as a prominent e-commerce platform since its founding in 2015, catering mainly to middle- and upper-class mothers.
PishPosh, Inc. (NASDAQ: BABY), an online retailer specializing in premium baby products, has priced its initial public offering (IPO) at
